CUBIST PHARMACEUTICALS INC
CBST
CBST was delisted on the 21st of January, 2015.
254 hedge funds and large institutions have $5.31B invested in CUBIST PHARMACEUTICALS INC in 2014 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 105 increasing their positions, 91 reducing their positions, and 38 closing their positions.
15% more repeat investments, than reductions
Existing positions increased: 105 | Existing positions reduced: 91
3% less capital invested
Capital invested by funds: $5.5B → $5.31B (-$188M)
6% less funds holding
Funds holding: 270 → 254 (-16)
18% less call options, than puts
Call options by funds: $35.7M | Put options by funds: $43.4M
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
34% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
+$61.1M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$60.3M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$49.6M |
| 4 |
Bank of New York Mellon
New York
|
+$40.1M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$20.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
-$39.6M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$37.2M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$27.8M |
| 4 |
RIM
RS Investment Management
San Francisco,
California
|
-$27.3M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$23.1M |
CBST Hedge Fund Activity: Q3 2014 in Review
254 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q3 2014, worth a combined $5.31B — down 3.4% from $5.5B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of CBST and 25 opened new positions — a net loss of 13 holders — while 91 trimmed existing stakes and 105 added.
The largest buyer was PointState Capital, adding an estimated $61.1M. The largest seller was OppenheimerFunds, exiting entirely with an estimated $39.6M sold.
- 254 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q3 2014, down from 270 in Q2 2014.
- Funds reported $5.31B of CUBIST PHARMACEUTICALS INC stock for Q3 2014, down 3.4% quarter-over-quarter.
- 25 funds opened new CUBIST PHARMACEUTICALS INC positions in Q3 2014 and 38 closed out, a net change of -13 holders.
- The largest CUBIST PHARMACEUTICALS INC buyer in Q3 2014 was PointState Capital, an estimated $61.1M added.
- The largest CUBIST PHARMACEUTICALS INC seller in Q3 2014 was OppenheimerFunds, an estimated $39.6M sold.
Based on aggregated 13F filings for Q3 2014.